These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

668 related articles for article (PubMed ID: 9362426)

  • 1. Skeletal complications of malignancy.
    Coleman RE
    Cancer; 1997 Oct; 80(8 Suppl):1588-94. PubMed ID: 9362426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features of metastatic bone disease and risk of skeletal morbidity.
    Coleman RE
    Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6243s-6249s. PubMed ID: 17062708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the treatment of bone metastases.
    Reich CD
    Clin J Oncol Nurs; 2003; 7(6):641-6. PubMed ID: 14705479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical treatment for pathologic fracture.
    Wedin R
    Acta Orthop Scand Suppl; 2001 Jun; 72(302):2p., 1-29. PubMed ID: 11582636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Payer costs for inpatient treatment of pathologic fracture, surgery to bone, and spinal cord compression among patients with multiple myeloma or bone metastasis secondary to prostate or breast cancer.
    Barlev A; Song X; Ivanov B; Setty V; Chung K
    J Manag Care Pharm; 2010; 16(9):693-702. PubMed ID: 21067255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic breast cancer confined to the skeletal system. An indolent disease.
    Sherry MM; Greco FA; Johnson DH; Hainsworth JD
    Am J Med; 1986 Sep; 81(3):381-6. PubMed ID: 2428242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bone metastasis in patients with breast cancer].
    Halaĭ OO
    Lik Sprava; 2003; (3-4):18-21. PubMed ID: 12889349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic bone disease: A review of survival, prognostic factors and outcomes following surgical treatment of the appendicular skeleton.
    Kirkinis MN; Lyne CJ; Wilson MD; Choong PF
    Eur J Surg Oncol; 2016 Dec; 42(12):1787-1797. PubMed ID: 27499111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bone metastases in lung cancer].
    Tsuya A; Fukuoka M
    Clin Calcium; 2008 Apr; 18(4):455-9. PubMed ID: 18379026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trials in metastatic breast cancer to bone: past--present--future.
    Body JJ
    Can J Oncol; 1995 Dec; 5 Suppl 1():16-27. PubMed ID: 8853520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonates for cancer patients: why, how, and when?
    Body JJ; Mancini I
    Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal-related events among breast and prostate cancer patients: towards new treatment initiation in Malaysia's hospital setting.
    Ezat SW; Syed Junid SM; Noraziani K; Zafar A; Saperi S; Nur AM; Aizuddin AN; Ismail F; Abdullah N; Zainuddin ZM; Mohd Kassim AY; Haflah NH
    Asian Pac J Cancer Prev; 2013; 14(5):3357-62. PubMed ID: 23803129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of skeletal complications in patients with metastatic breast carcinoma.
    Domchek SM; Younger J; Finkelstein DM; Seiden MV
    Cancer; 2000 Jul; 89(2):363-8. PubMed ID: 10918167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.
    Body JJ; Bartl R; Burckhardt P; Delmas PD; Diel IJ; Fleisch H; Kanis JA; Kyle RA; Mundy GR; Paterson AH; Rubens RD
    J Clin Oncol; 1998 Dec; 16(12):3890-9. PubMed ID: 9850035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of bone metastases].
    Nagykálnai T; Landherr L
    Orv Hetil; 2014 Feb; 155(6):217-25. PubMed ID: 24486845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bone targeting agents: bisphosphonates].
    Debiais F
    Bull Cancer; 2013 Nov; 100(11):1199-206. PubMed ID: 24158668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of bone metastasis.
    Mundy GR
    Cancer; 1997 Oct; 80(8 Suppl):1546-56. PubMed ID: 9362421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonates for breast cancer.
    Pavlakis N; Stockler M
    Cochrane Database Syst Rev; 2002; (1):CD003474. PubMed ID: 11869664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost of treatment of skeletal-related events in patients with bone metastases from lung cancer.
    Delea T; Langer C; McKiernan J; Liss M; Edelsberg J; Brandman J; Sung J; Raut M; Oster G
    Oncology; 2004; 67(5-6):390-6. PubMed ID: 15713995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone metastases: pathogenesis, treatment, and rationale for use of resorption inhibitors.
    Scher HI; Yagoda A
    Am J Med; 1987 Feb; 82(2A):6-28. PubMed ID: 3548343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.